Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-05-03 @ 9:02 AM
Study NCT ID:
NCT02795767
Status:
COMPLETED
Last Update Posted:
2021-06-02
First Post:
2016-06-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BH29992
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |